Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors or Tamoxifen

被引：0
作者：
Lintermans, A.
Dieudonne, A. S.
Vanderhaegen, J. [1 ]
Henry, N. L. [2 ]
Wildiers, H. [3 ]
Paridaens, R. [3 ]
Christiaens, M. R. [3 ]
Smeets, A. [3 ]
Leunen, K. [3 ]
Neven, P. [3 ]
机构：
[1] Katholieke Univ Leuven Hosp, Gynecol Multidisciplinary Breast Ctr, Louvain, Belgium
[2] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[3] Katholieke Univ Leuven Hosp, Multidisciplinary Breast Ctr, Louvain, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [21] Compliance and persistence of tamoxifen and aromatase inhibitors in breast cancer patients
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 96 - 97
  • [22] Assessment of hot flashes and clinical correlates in breast cancer patients receiving tamoxifen or third-generation aromatase inhibitors.
    Morales, L
    Neven, P
    Cheroutre, E
    vande Putte, G
    Paridaens, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 732S - 732S
  • [23] Cognitive complaints among Tunisian breast cancer patients receiving adjuvant aromatase-inhibitors
    Ben Abdallah, I.
    Rachdi, H.
    Dhib, D.
    Mejri, N.
    Berrazega, Y.
    El Benna, H.
    Daoud, N.
    Laabidi, S.
    Boussen, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S83 - S83
  • [24] Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
    van de Velde, C. J. H.
    Verma, S.
    van Nes, J. G. H.
    Masterman, C.
    Pritchard, K. I.
    CANCER TREATMENT REVIEWS, 2010, 36 (01) : 54 - 62
  • [25] Adherence challenges in breast cancer: Evaluating tamoxifen and aromatase inhibitors in adjuvant hormone therapy
    Camejo, N.
    Amarillo, D.
    Castillo, C.
    Argenzio, L.
    Santana, D.
    Herrera, G.
    Cabrera, L.
    Guerrina, M.
    Dorner, C.
    Krygier, G.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 35 - 36
  • [26] Quality of Life of Women With Breast Cancer Treated in Adjuvant Setting With Tamoxifen or Aromatase Inhibitors
    Volovat, S.
    Apostol, D.
    Volovat, C.
    Carausu, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S379 - S379
  • [27] Impact of obesity in postmenopausal early breast cancer patients receiving frontline adjuvant aromatase inhibitors.
    Sahin, Ugur
    Petekkaya, Ibrahim
    Arslan, Cagatay
    Sarici, Saim Furkan
    Solak, Mustafa
    Keskin, Ozge
    Ozisik, Yavuz Yasin
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results
    Yoshimi Ouchi
    Katsuhiko Nakatsukasa
    Koichi Sakaguchi
    Midori Morita
    Hiroshi Koyama
    Takayuki Matsuda
    Makoto Kato
    Eiichi Konishi
    Hisako Ono
    Tetsuya Taguchi
    Journal of Bone and Mineral Metabolism, 2021, 39 : 224 - 229
  • [29] The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results
    Ouchi, Yoshimi
    Nakatsukasa, Katsuhiko
    Sakaguchi, Koichi
    Morita, Midori
    Koyama, Hiroshi
    Matsuda, Takayuki
    Kato, Makoto
    Konishi, Eiichi
    Ono, Hisako
    Taguchi, Tetsuya
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (02) : 224 - 229
  • [30] Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor
    Kuria, I. M.
    Petekkaya, I.
    Hasanov, E.
    Babacan, T.
    Dizdar, O.
    Altundag, K.
    JOURNAL OF BUON, 2012, 17 (04): : 798 - 799
12345